Modulation of innate and adaptive immunity by biodegradable nanoparticles

Immunology Letters

Volumn 125, Issue 1, 2009, Pages 46-52

  Uto, Tomofumi ^a,c   Akagi, Takami ^b,c   Hamasaki, Takayuki ^a   Akashi, Mitsuru ^b,c   Baba, Masanori ^a,c  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Adaptive immunity; Adjuvant; Innate immunity; Nanoparticle; Vaccine

Indexed keywords

CD8 ANTIGEN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; NANOPARTICLE; OVALBUMIN; POLYGLUTAMIC ACID; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BIODEGRADABILITY; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; HUMORAL IMMUNITY; IMMUNIZATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNITY, ACTIVE; IMMUNITY, INNATE; IMMUNIZATION; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; NANOPARTICLES; NF-KAPPA B; OVALBUMIN; POLYGLUTAMIC ACID; SIGNAL TRANSDUCTION; SPLEEN;

EID: 67649920882     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.05.008     Document Type: Article

References (22)

1. Moore A.C., and Hill A.V. Progress in DNA-based heterologous prime-boost immunization strategies for malaria. Immunol Rev 199 (2004) 126-143
2. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 4 (1998) 397-402
3. Letvin N.L., Barouch D.H., and Montefiori D.C. Prospects for vaccine protection against HIV-1 infection and AIDS. Annu Rev Immunol 20 (2002) 73-99
4. + lymphocytes as compared with nonprofessional APC. J Immunol 167 (2001) 1188-1197
5. Smyth L.A., Harker N., Turnbull W., El-Doueik H., Klavinskis L., Kioussis D., et al. The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type. J Immunol 181 (2008) 3212-3220
6. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
7. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5 (2004) 987-995
8. Lore K., Betts M.R., Brenchley J.M., Kuruppu J., Khojasteh S., Perfetto S., et al. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J Immunol 171 (2003) 4320-4328
9. Porgador A., and Gilboa E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 182 (1995) 255-260
10. Wang X., Uto T., Sato K., Ide K., Akagi T., Okamoto M., et al. Potent activation of antigen-specific T cells by antigen-loaded nanospheres. Immunol Lett 98 (2005) 123-130
11. Kawamura M., Naito T., Ueno M., Akagi T., Hiraishi K., Takai I., et al. Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice. J Med Virol 66 (2002) 291-298
12. Akagi T., Higashi M., Kaneko T., Kida T., and Akashi M. In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(γ-glutamic acid). Macromol Biosci 5 (2005) 598-602
13. Uto T., Wang X., Akagi T., Zenkyu R., Akashi M., and Baba M. Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles. Biochem Biophys Res Commun 379 (2009) 600-604
14. Uto T., Wang X., Sato K., Haraguchi M., Akagi T., Akashi M., et al. Targeting of antigen to dendritic cells with poly(γ-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immunol 178 (2007) 2979-2986
15. + T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120. J Virol 81 (2007) 10009-10016
16. + T-cell memory and prime-boost response after dendritic-cell vaccination. Nat Med 11 (2005) 748-756
17. Luci C., Hervouet C., Rousseau D., Holmgren J., Czerkinsky C., and Anjuere F. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin. J Immunol 176 (2006) 2749-2757
18. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
19. Manickasingham S.P., Edwards A.D., Schulz O., and Reis e Sousa C. The ability of murine dendritic cell subsets to direct T helper cell differentiation is dependent on microbial signals. Eur J Immunol 33 (2003) 101-107
20. Shortman K., and Caux C. Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells 15 (1997) 409-419
21. Masson F., Mount A.M., Wilson N.S., and Belz G.T. Dendritic cells: driving the differentiation programme of T cells in viral infections. Immunol Cell Biol 86 (2008) 333-342
22. - dendritic cells: a dispensable role for TAP. Eur J Immunol 32 (2002) 818-825